TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
565,095
|
323,911
|
156,244 |
| Financial expenses |
17,510
|
99,438
|
19,300 |
| Earnings before taxes |
20,139
|
11,024
|
17,943 |
| EBITDA |
9,308
|
-9,601
|
9,179 |
| Total assets |
266,110
|
205,534
|
200,137 |
| Current assets |
264,714
|
196,024
|
198,625 |
| Current liabilities |
202,320
|
158,906
|
159,517 |
| Equity capital |
61,499
|
45,378
|
39,917 |
| - share capital |
1,343
|
1,336
|
1,454 |
| Employees (average) |
14
|
14
|
14 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
23.1%
|
22.1%
|
19.9% |
| Turnover per employee |
40,364
|
23,136
|
11,160 |
| Profit as a percentage of turnover |
3.6%
|
3.4%
|
11.5% |
| Return on assets (ROA) |
14.1%
|
53.7%
|
18.6% |
| Current ratio |
130.8%
|
123.4%
|
124.5% |
| Return on equity (ROE) |
32.7%
|
24.3%
|
45.0% |
| Change turnover |
239,515
|
180,323
|
106,223 |
| Change turnover % |
74%
|
126%
|
212% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.